List view / Grid view
"Well thought through and brilliantly executed" study shows different DNA-repair…
"Well thought through and brilliantly executed" study shows different DNA-repair mechanism in embryos compared to iPSCs
Metrion Biosciences Limited and LifeArc, today announced an extension of…
Metrion Biosciences Limited and LifeArc, today announced an extension of their existing partnership...
A collaboration to investigate the link between epigenetics and respiratory…
1 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A collaboration to investigate the link between epigenetics and respiratory disease and to find new drug treatments involves...
MRCT and AstraZeneca are seeking academics with relevant epigenetics targets…
15 June 2016 | By Victoria White, Digital Content Producer
MRCT and AstraZeneca are seeking academics with relevant epigenetics targets to collaborate with them to develop novel treatments for respiratory diseases...
Disregulation of MALT1 is associated with some subsets of lymphoma…
24 September 2015 | By Victoria White
Disregulation of MALT1 is associated with some subsets of lymphoma suggesting that MALT1 could be a promising drug target for these types of cancer...
A team at the International Centre for Genetic Engineering and…
16 September 2015 | By Victoria White
A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
Academia and pharma have always been uneasy bedfellows. There has…
Academia and pharma have always been uneasy bedfellows. There has in the past been tension between both caused by a range of issues that neither party was willing to try and resolve. However, there is a new impetus to solve these issues as both parties have started to realise that…
Editor Caroline Richards talks about the editorial board members who…
Editor Caroline Richards talks about the editorial board members who have influenced the content coming up in the latest issue of Drug Target Review, available in April 2015...
New breakthrough immunotherapy (pembrolizumab) launched in the UK for treatment…
11 March 2015 | By MRC Technology
New breakthrough immunotherapy (pembrolizumab) launched in the UK for treatment of adults with advanced melanoma...
Project focused on potential small molecule or antibody targets in…
2 March 2015 | By MRC Technology
Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease...
Initiative brings together global expertise to share compound libraries and…
3 July 2014 | By MRC Technology
Initiative brings together global expertise to share compound libraries and streamline drug discovery...
Executive Director of Drug Discovery at LifeArc
6 November 2013 | By
Executive Director of Drug Discovery at LifeArc
Justin Bryans talks to Drug Target Review about his work…
Justin Bryans talks to Drug Target Review about his work as Director of Drug Discovery at the Centre for Therapeutics Discovery, MRC Technology. Justin is also a member of the Drug Target Review Editorial Board.
